Head and Neck Cancer
1 competing product in clinical development for Head and Neck Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + Cetuximab | BioAtla | Phase 2 | Completed | 44 |